These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 27774765)

  • 41. Genomics and breast cancer screening.
    Tyler AL
    J Am Assoc Nurse Pract; 2019 Sep; 31(9):485-487. PubMed ID: 31490845
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HER2 Immunohistochemistry-Guided Targeted Fluorescence In Situ Hybridization Analysis Does Not Help Identify Intratumoral Heterogeneity in Breast Cancer.
    Gulbahce HE; Factor R; Geiersbach K; Downs-Kelly E
    Arch Pathol Lab Med; 2016 Aug; 140(8):741. PubMed ID: 27472230
    [No Abstract]   [Full Text] [Related]  

  • 43. Genetic and Genomic Advances in Breast Cancer Diagnosis and Treatment.
    Walker-Smith TL; Peck J
    Nurs Womens Health; 2019 Dec; 23(6):518-525. PubMed ID: 31669147
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Circulating tumour cells: insights into tumour heterogeneity.
    Hayes DF; Paoletti C
    J Intern Med; 2013 Aug; 274(2):137-43. PubMed ID: 23844916
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Breast cancer genome heterogeneity: a challenge to personalised medicine?
    Swanton C; Burrell RA; Futreal PA
    Breast Cancer Res; 2011 Feb; 13(1):104. PubMed ID: 21345264
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multigene prognostic tests in breast cancer: past, present, future.
    Győrffy B; Hatzis C; Sanft T; Hofstatter E; Aktas B; Pusztai L
    Breast Cancer Res; 2015 Jan; 17(1):11. PubMed ID: 25848861
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Breast cancer diagnosis: Imaging techniques and biochemical markers.
    Jafari SH; Saadatpour Z; Salmaninejad A; Momeni F; Mokhtari M; Nahand JS; Rahmati M; Mirzaei H; Kianmehr M
    J Cell Physiol; 2018 Jul; 233(7):5200-5213. PubMed ID: 29219189
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intratumor genomic heterogeneity in breast cancer with clonal divergence between primary carcinomas and lymph node metastases.
    Torres L; Ribeiro FR; Pandis N; Andersen JA; Heim S; Teixeira MR
    Breast Cancer Res Treat; 2007 Apr; 102(2):143-55. PubMed ID: 16906480
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Integrating clinicopathologic and genomic tools in chemotherapy decision-making for early stage breast cancer.
    Havard R; Henry NL
    Future Oncol; 2017 Dec; 13(28):2507-2510. PubMed ID: 29168654
    [No Abstract]   [Full Text] [Related]  

  • 50. [The genetic basis and clinical application of heterogeneity of breast cancer].
    Li T
    Zhonghua Wai Ke Za Zhi; 2017 Feb; 55(2):104-108. PubMed ID: 28162208
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genomic Biomarkers for Breast Cancer Risk.
    Walsh MF; Nathanson KL; Couch FJ; Offit K
    Adv Exp Med Biol; 2016; 882():1-32. PubMed ID: 26987529
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intratumoral Heterogeneity in Breast Cancer: A Comparison of Primary and Metastatic Breast Cancers.
    Shi YJ; Tsang JY; Ni YB; Tse GM
    Oncologist; 2017 Apr; 22(4):487-490. PubMed ID: 28341760
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of genomics on adjuvant treatments for pre-invasive and invasive breast cancer.
    Abu-Khalf M; Pusztai L
    Breast; 2013 Aug; 22 Suppl 2():S83-7. PubMed ID: 24074799
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pathologic diagnosis, immunohistochemistry, multigene assays and breast cancer treatment: progress toward "precision" cancer therapy.
    Hicks DG; Turner B
    Biotech Histochem; 2015 Feb; 90(2):81-92. PubMed ID: 25434396
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diagnosis of breast cancer in women age 40 and younger: delays in diagnosis result from underuse of genetic testing and breast imaging.
    Samphao S; Wheeler AJ; Rafferty E; Michaelson JS; Specht MC; Gadd MA; Hughes KS; Smith BL
    Am J Surg; 2009 Oct; 198(4):538-43. PubMed ID: 19800464
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Unravelling tumour heterogeneity using next-generation imaging: radiomics, radiogenomics, and habitat imaging.
    Sala E; Mema E; Himoto Y; Veeraraghavan H; Brenton JD; Snyder A; Weigelt B; Vargas HA
    Clin Radiol; 2017 Jan; 72(1):3-10. PubMed ID: 27742105
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): interim results.
    Sardanelli F; Podo F; D'Agnolo G; Verdecchia A; Santaquilani M; Musumeci R; Trecate G; Manoukian S; Morassut S; de Giacomi C; Federico M; Cortesi L; Corcione S; Cirillo S; Marra V; ; Cilotti A; Di Maggio C; Fausto A; Preda L; Zuiani C; Contegiacomo A; Orlacchio A; Calabrese M; Bonomo L; Di Cesare E; Tonutti M; Panizza P; Del Maschio A
    Radiology; 2007 Mar; 242(3):698-715. PubMed ID: 17244718
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intra-tumor heterogeneity in breast cancer has limited impact on transcriptomic-based molecular profiling.
    Karthik GM; Rantalainen M; Stålhammar G; Lövrot J; Ullah I; Alkodsi A; Ma R; Wedlund L; Lindberg J; Frisell J; Bergh J; Hartman J
    BMC Cancer; 2017 Nov; 17(1):802. PubMed ID: 29187174
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Breast Cancer Detection by B7-H3-Targeted Ultrasound Molecular Imaging.
    Bachawal SV; Jensen KC; Wilson KE; Tian L; Lutz AM; Willmann JK
    Cancer Res; 2015 Jun; 75(12):2501-9. PubMed ID: 25899053
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Current breast imaging modalities, advances, and impact on breast care.
    Garcia EM; Storm ES; Atkinson L; Kenny E; Mitchell LS
    Obstet Gynecol Clin North Am; 2013 Sep; 40(3):429-57. PubMed ID: 24021251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.